These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Insulin secretion from ob/ob mouse pancreatic islets: effects of neurotransmitters. Tassava TM; Okuda T; Romsos DR Am J Physiol; 1992 Mar; 262(3 Pt 1):E338-43. PubMed ID: 1550226 [TBL] [Abstract][Full Text] [Related]
5. Dopamine agonist treatment ameliorates hyperglycemia, hyperlipidemia, and the elevated basal insulin release from islets of ob/ob mice. Liang Y; Lubkin M; Sheng H; Scislowski PW; Cincotta AH Biochim Biophys Acta; 1998 Oct; 1405(1-3):1-13. PubMed ID: 9784590 [TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse. Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737 [TBL] [Abstract][Full Text] [Related]
7. Adrenalectomy suppresses insulin secretion from pancreatic islets of ob/ob mice. Okuda T; Romsos DR Int J Obes Relat Metab Disord; 1994 Dec; 18(12):801-5. PubMed ID: 7894518 [TBL] [Abstract][Full Text] [Related]
8. Interactions between insulin and glucocorticoids in the maintenance of genetic obesity. Dubuc PU Am J Physiol; 1992 Sep; 263(3 Pt 1):E550-5. PubMed ID: 1415535 [TBL] [Abstract][Full Text] [Related]
9. Insulin production by pancreatic islets of obese-hyperglycemic mice cultured for one week in different glucose concentrations. Andersson A; Asplund K; Larkins R Acta Physiol Scand; 1978 Dec; 104(4):377-85. PubMed ID: 364930 [TBL] [Abstract][Full Text] [Related]
11. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse. Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265 [TBL] [Abstract][Full Text] [Related]
12. The relationship between the hyperplastic pancreatic islet and insulin insensitivity in obesity. Mahler RJ Acta Diabetol Lat; 1981; 18(1):1-17. PubMed ID: 6452013 [TBL] [Abstract][Full Text] [Related]
13. Insulin secretion and the morphological and metabolic characteristics of pancreatic islets of hyperthyroid ob/ob mice. Lenzen S; Klöppel G Endocrinology; 1978 Nov; 103(5):1546-55. PubMed ID: 371951 [TBL] [Abstract][Full Text] [Related]
14. Abnormally decreased NO and augmented CO production in islets of the leptin-deficient ob/ob mouse might contribute to explain hyperinsulinemia and islet survival in leptin-resistant type 2 obese diabetes. Jimenez-Feltstrom J; Salehi A; Meidute Abaraviciene S; Henningsson R; Lundquist I Regul Pept; 2011 Oct; 170(1-3):43-51. PubMed ID: 21620903 [TBL] [Abstract][Full Text] [Related]
15. VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity. Watson E; Hahm S; Mizuno TM; Windsor J; Montgomery C; Scherer PE; Mobbs CV; Salton SR Endocrinology; 2005 Dec; 146(12):5151-63. PubMed ID: 16141392 [TBL] [Abstract][Full Text] [Related]
17. Effect of fasting and streptozotocin in the obese-hyperglycemic (ob/ob) mouse. Apparent lack of a direct relationship between insulin binding and insulin effects. Le Marchand Y; Loten EG; Assimacopoulos-Jeannet F; Forgue ME; Freychet P; Jeanrenaud B Diabetes; 1977 Jun; 26(6):582-90. PubMed ID: 140828 [TBL] [Abstract][Full Text] [Related]
18. Carbon monoxide stimulates insulin release and propagates Ca2+ signals between pancreatic beta-cells. Lundquist I; Alm P; Salehi A; Henningsson R; Grapengiesser E; Hellman B Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1055-63. PubMed ID: 14534076 [TBL] [Abstract][Full Text] [Related]
19. Development of insulin secretory function in young obese hyperglycemic mice (Umeå ob/ob). Edvell A; Lindström P Metabolism; 1995 Jul; 44(7):906-13. PubMed ID: 7616850 [TBL] [Abstract][Full Text] [Related]